BETA 10-Q Details Q3 Revenue of $17.7M, $1.34B Cash and New CEO/CFO Selling Plans
BETA sits 64% above its 52-week low of $13.43.
Summary
BETA's Q3 10-Q backs up this morning's record $17.7 million revenue and raised $52-57 million guidance with full financials, showing $1.34 billion of cash after $367 million of nine-month burn. It also discloses new CEO and CFO 10b5-1 selling plans covering up to roughly 1.04 million shares through early 2027.
Key Events · Earnings and Guidance · BETA
-
Q3 Revenue Nearly Doubles
Revenue of $17.7 million for the quarter, up 98% from $8.9 million a year earlier, with nine-month revenue of $42.5 million versus $24.5 million.
-
Cash Falls on Heavy Burn
Cash and equivalents of $1,343.1 million at September 30, 2026, down from $1,710.2 million at December 31, 2025 — a $367.2 million decline on $271.4 million of operating cash use and $103.8 million of investing outflows.
-
Losses Widen With R&D
Net loss of $119.1 million for the quarter and $390.2 million for nine months, as research and development expense rose to $90.5 million in Q3 from $56.4 million.
-
New Insider Selling Plans
CEO Kyle Clark's trust adopted plans for up to 300,000 shares (Nov 13-Dec 14, 2026), 250,000 shares (Dec 15, 2026-Jan 11, 2027) and 270,000 shares (Jan 12-Feb 22, 2027); CFO Herman Cueto adopted a plan for up to 216,661 shares from about November 16, 2026 through April 30, 2027.
Analysis · BETA · Manufacturing
The headline numbers were already out this morning, but the full 10-Q is where the balance sheet lives: cash fell to $1.34 billion from $1.71 billion at year-end, a $367 million draw over nine months driven by $271 million of operating burn and $104 million of capex. At that pace the company has roughly three to four years of runway, so the guidance raise to $52-57 million matters more for credibility than for cash. The item traders may not have priced is the cluster of new 10b5-1 plans: the CEO has staggered programs covering up to 820,000 shares across windows running from November 2026 into February 2027, and the CFO has one for up to 216,661 shares starting mid-November. That is scheduled supply hitting the market over the next several months, on top of the $11.9 million of insider sales already logged in the past 90 days.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 40.9% of the 1143 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.37%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BETA was trading at $22.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $13.43 to $39.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.